HomeCLN • WSE
add
Celon Pharma SA
Previous close
zł 22.00
Day range
zł 21.60 - zł 22.55
Year range
zł 15.44 - zł 32.90
Market cap
1.21B PLN
Avg Volume
18.98K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 49.08M | 25.98% |
Operating expense | 48.66M | 11.20% |
Net income | -25.09M | -60.08% |
Net profit margin | -51.11 | -27.04% |
Earnings per share | — | — |
EBITDA | -9.27M | -79.98% |
Effective tax rate | -11.45% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 52.52M | -52.60% |
Total assets | 521.20M | -5.60% |
Total liabilities | 101.67M | -17.46% |
Total equity | 419.53M | — |
Shares outstanding | 53.86M | — |
Price to book | 2.82 | — |
Return on assets | -8.86% | — |
Return on capital | -10.47% | — |
Cash Flow
Net change in cash
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -25.09M | -60.08% |
Cash from operations | -11.41M | -106.55% |
Cash from investing | 7.31M | -22.06% |
Cash from financing | 621.00K | 117.87% |
Net change in cash | -3.48M | -1,021.16% |
Free cash flow | -9.62M | -1,041.59% |
About
Founded
2002
Website
Employees
567
